nodes	percent_of_prediction	percent_of_DWPC	metapath
Carbinoxamine—CYP2B6—Tretinoin—peripheral nervous system neoplasm	0.13	0.167	CbGbCtD
Carbinoxamine—CYP2E1—Dacarbazine—peripheral nervous system neoplasm	0.113	0.146	CbGbCtD
Carbinoxamine—CYP2C8—Tretinoin—peripheral nervous system neoplasm	0.0985	0.127	CbGbCtD
Carbinoxamine—CYP2C9—Tretinoin—peripheral nervous system neoplasm	0.0687	0.0884	CbGbCtD
Carbinoxamine—CYP2B6—Cisplatin—peripheral nervous system neoplasm	0.0557	0.0716	CbGbCtD
Carbinoxamine—CYP2E1—Etoposide—peripheral nervous system neoplasm	0.0555	0.0713	CbGbCtD
Carbinoxamine—CYP3A4—Topotecan—peripheral nervous system neoplasm	0.043	0.0553	CbGbCtD
Carbinoxamine—CYP2C8—Etoposide—peripheral nervous system neoplasm	0.0415	0.0533	CbGbCtD
Carbinoxamine—CYP3A4—Tretinoin—peripheral nervous system neoplasm	0.04	0.0514	CbGbCtD
Carbinoxamine—CYP2B6—Doxorubicin—peripheral nervous system neoplasm	0.0373	0.048	CbGbCtD
Carbinoxamine—CYP2C9—Cisplatin—peripheral nervous system neoplasm	0.0294	0.0378	CbGbCtD
Carbinoxamine—CYP3A4—Vincristine—peripheral nervous system neoplasm	0.0184	0.0236	CbGbCtD
Carbinoxamine—CYP2D6—Doxorubicin—peripheral nervous system neoplasm	0.018	0.0232	CbGbCtD
Carbinoxamine—CYP3A4—Etoposide—peripheral nervous system neoplasm	0.0168	0.0216	CbGbCtD
Carbinoxamine—CYP3A4—Doxorubicin—peripheral nervous system neoplasm	0.0115	0.0147	CbGbCtD
Carbinoxamine—Palpitations—Tretinoin—peripheral nervous system neoplasm	0.000916	0.00412	CcSEcCtD
Carbinoxamine—Palpitations—Isotretinoin—peripheral nervous system neoplasm	0.000916	0.00412	CcSEcCtD
Carbinoxamine—Convulsion—Tretinoin—peripheral nervous system neoplasm	0.000898	0.00404	CcSEcCtD
Carbinoxamine—Convulsion—Isotretinoin—peripheral nervous system neoplasm	0.000898	0.00404	CcSEcCtD
Carbinoxamine—Convulsion—Melphalan—peripheral nervous system neoplasm	0.000886	0.00399	CcSEcCtD
Carbinoxamine—Chills—Dactinomycin—peripheral nervous system neoplasm	0.000873	0.00393	CcSEcCtD
Carbinoxamine—Sweating increased—Etoposide—peripheral nervous system neoplasm	0.000857	0.00386	CcSEcCtD
Carbinoxamine—Confusional state—Tretinoin—peripheral nervous system neoplasm	0.000853	0.00384	CcSEcCtD
Carbinoxamine—Confusional state—Isotretinoin—peripheral nervous system neoplasm	0.000853	0.00384	CcSEcCtD
Carbinoxamine—Tinnitus—Alitretinoin—peripheral nervous system neoplasm	0.000841	0.00379	CcSEcCtD
Carbinoxamine—Neuropathy peripheral—Cisplatin—peripheral nervous system neoplasm	0.000839	0.00378	CcSEcCtD
Carbinoxamine—Thrombocytopenia—Topotecan—peripheral nervous system neoplasm	0.000835	0.00376	CcSEcCtD
Carbinoxamine—Thrombocytopenia—Tretinoin—peripheral nervous system neoplasm	0.000828	0.00373	CcSEcCtD
Carbinoxamine—Thrombocytopenia—Isotretinoin—peripheral nervous system neoplasm	0.000828	0.00373	CcSEcCtD
Carbinoxamine—Tachycardia—Isotretinoin—peripheral nervous system neoplasm	0.000825	0.00371	CcSEcCtD
Carbinoxamine—Tachycardia—Tretinoin—peripheral nervous system neoplasm	0.000825	0.00371	CcSEcCtD
Carbinoxamine—Hyperhidrosis—Topotecan—peripheral nervous system neoplasm	0.000824	0.00371	CcSEcCtD
Carbinoxamine—Hyperhidrosis—Tretinoin—peripheral nervous system neoplasm	0.000817	0.00368	CcSEcCtD
Carbinoxamine—Hyperhidrosis—Isotretinoin—peripheral nervous system neoplasm	0.000817	0.00368	CcSEcCtD
Carbinoxamine—Thrombocytopenia—Melphalan—peripheral nervous system neoplasm	0.000817	0.00368	CcSEcCtD
Carbinoxamine—Tachycardia—Melphalan—peripheral nervous system neoplasm	0.000815	0.00367	CcSEcCtD
Carbinoxamine—Anorexia—Topotecan—peripheral nervous system neoplasm	0.000812	0.00366	CcSEcCtD
Carbinoxamine—Chills—Alitretinoin—peripheral nervous system neoplasm	0.000809	0.00364	CcSEcCtD
Carbinoxamine—Anorexia—Tretinoin—peripheral nervous system neoplasm	0.000806	0.00363	CcSEcCtD
Carbinoxamine—Anorexia—Isotretinoin—peripheral nervous system neoplasm	0.000806	0.00363	CcSEcCtD
Carbinoxamine—Anorexia—Melphalan—peripheral nervous system neoplasm	0.000796	0.00358	CcSEcCtD
Carbinoxamine—Hypotension—Tretinoin—peripheral nervous system neoplasm	0.00079	0.00356	CcSEcCtD
Carbinoxamine—Hypotension—Isotretinoin—peripheral nervous system neoplasm	0.00079	0.00356	CcSEcCtD
Carbinoxamine—Hypotension—Melphalan—peripheral nervous system neoplasm	0.00078	0.00351	CcSEcCtD
Carbinoxamine—Tension—Alitretinoin—peripheral nervous system neoplasm	0.00077	0.00347	CcSEcCtD
Carbinoxamine—Neuropathy peripheral—Etoposide—peripheral nervous system neoplasm	0.000769	0.00346	CcSEcCtD
Carbinoxamine—Paraesthesia—Topotecan—peripheral nervous system neoplasm	0.000765	0.00345	CcSEcCtD
Carbinoxamine—Insomnia—Isotretinoin—peripheral nervous system neoplasm	0.000765	0.00344	CcSEcCtD
Carbinoxamine—Insomnia—Tretinoin—peripheral nervous system neoplasm	0.000765	0.00344	CcSEcCtD
Carbinoxamine—Nervousness—Alitretinoin—peripheral nervous system neoplasm	0.000763	0.00343	CcSEcCtD
Carbinoxamine—Paraesthesia—Tretinoin—peripheral nervous system neoplasm	0.000759	0.00342	CcSEcCtD
Carbinoxamine—Paraesthesia—Isotretinoin—peripheral nervous system neoplasm	0.000759	0.00342	CcSEcCtD
Carbinoxamine—Somnolence—Isotretinoin—peripheral nervous system neoplasm	0.000752	0.00338	CcSEcCtD
Carbinoxamine—Somnolence—Tretinoin—peripheral nervous system neoplasm	0.000752	0.00338	CcSEcCtD
Carbinoxamine—Dyspepsia—Topotecan—peripheral nervous system neoplasm	0.00075	0.00338	CcSEcCtD
Carbinoxamine—Paraesthesia—Melphalan—peripheral nervous system neoplasm	0.000749	0.00337	CcSEcCtD
Carbinoxamine—Dyspepsia—Tretinoin—peripheral nervous system neoplasm	0.000744	0.00335	CcSEcCtD
Carbinoxamine—Dyspepsia—Isotretinoin—peripheral nervous system neoplasm	0.000744	0.00335	CcSEcCtD
Carbinoxamine—Decreased appetite—Topotecan—peripheral nervous system neoplasm	0.000741	0.00334	CcSEcCtD
Carbinoxamine—Vision blurred—Alitretinoin—peripheral nervous system neoplasm	0.00074	0.00333	CcSEcCtD
Carbinoxamine—Tremor—Alitretinoin—peripheral nervous system neoplasm	0.000736	0.00331	CcSEcCtD
Carbinoxamine—Decreased appetite—Isotretinoin—peripheral nervous system neoplasm	0.000735	0.00331	CcSEcCtD
Carbinoxamine—Decreased appetite—Tretinoin—peripheral nervous system neoplasm	0.000735	0.00331	CcSEcCtD
Carbinoxamine—Fatigue—Topotecan—peripheral nervous system neoplasm	0.000735	0.00331	CcSEcCtD
Carbinoxamine—Dyspepsia—Melphalan—peripheral nervous system neoplasm	0.000735	0.00331	CcSEcCtD
Carbinoxamine—Agranulocytosis—Etoposide—peripheral nervous system neoplasm	0.000732	0.00329	CcSEcCtD
Carbinoxamine—Fatigue—Tretinoin—peripheral nervous system neoplasm	0.000729	0.00328	CcSEcCtD
Carbinoxamine—Fatigue—Isotretinoin—peripheral nervous system neoplasm	0.000729	0.00328	CcSEcCtD
Carbinoxamine—Constipation—Topotecan—peripheral nervous system neoplasm	0.000729	0.00328	CcSEcCtD
Carbinoxamine—Decreased appetite—Melphalan—peripheral nervous system neoplasm	0.000725	0.00327	CcSEcCtD
Carbinoxamine—Constipation—Isotretinoin—peripheral nervous system neoplasm	0.000723	0.00325	CcSEcCtD
Carbinoxamine—Constipation—Tretinoin—peripheral nervous system neoplasm	0.000723	0.00325	CcSEcCtD
Carbinoxamine—Agitation—Alitretinoin—peripheral nervous system neoplasm	0.000722	0.00325	CcSEcCtD
Carbinoxamine—Fatigue—Melphalan—peripheral nervous system neoplasm	0.00072	0.00324	CcSEcCtD
Carbinoxamine—Tinnitus—Cisplatin—peripheral nervous system neoplasm	0.000716	0.00323	CcSEcCtD
Carbinoxamine—Feeling abnormal—Topotecan—peripheral nervous system neoplasm	0.000702	0.00316	CcSEcCtD
Carbinoxamine—Feeling abnormal—Tretinoin—peripheral nervous system neoplasm	0.000697	0.00314	CcSEcCtD
Carbinoxamine—Feeling abnormal—Isotretinoin—peripheral nervous system neoplasm	0.000697	0.00314	CcSEcCtD
Carbinoxamine—Agitation—Vincristine—peripheral nervous system neoplasm	0.000695	0.00313	CcSEcCtD
Carbinoxamine—Palpitations—Alitretinoin—peripheral nervous system neoplasm	0.000694	0.00312	CcSEcCtD
Carbinoxamine—Convulsion—Alitretinoin—peripheral nervous system neoplasm	0.00068	0.00306	CcSEcCtD
Carbinoxamine—Vertigo—Vincristine—peripheral nervous system neoplasm	0.00068	0.00306	CcSEcCtD
Carbinoxamine—Urticaria—Topotecan—peripheral nervous system neoplasm	0.000677	0.00305	CcSEcCtD
Carbinoxamine—Thrombocytopenia—Dactinomycin—peripheral nervous system neoplasm	0.000677	0.00305	CcSEcCtD
Carbinoxamine—Urticaria—Tretinoin—peripheral nervous system neoplasm	0.000672	0.00302	CcSEcCtD
Carbinoxamine—Urticaria—Isotretinoin—peripheral nervous system neoplasm	0.000672	0.00302	CcSEcCtD
Carbinoxamine—Urticaria—Melphalan—peripheral nervous system neoplasm	0.000663	0.00298	CcSEcCtD
Carbinoxamine—Anorexia—Dactinomycin—peripheral nervous system neoplasm	0.000659	0.00297	CcSEcCtD
Carbinoxamine—Convulsion—Vincristine—peripheral nervous system neoplasm	0.000655	0.00295	CcSEcCtD
Carbinoxamine—Photosensitivity—Epirubicin—peripheral nervous system neoplasm	0.00065	0.00292	CcSEcCtD
Carbinoxamine—Confusional state—Alitretinoin—peripheral nervous system neoplasm	0.000646	0.00291	CcSEcCtD
Carbinoxamine—Chills—Etoposide—peripheral nervous system neoplasm	0.000632	0.00284	CcSEcCtD
Carbinoxamine—Vision blurred—Cisplatin—peripheral nervous system neoplasm	0.00063	0.00284	CcSEcCtD
Carbinoxamine—Thrombocytopenia—Alitretinoin—peripheral nervous system neoplasm	0.000627	0.00282	CcSEcCtD
Carbinoxamine—Tremor—Cisplatin—peripheral nervous system neoplasm	0.000627	0.00282	CcSEcCtD
Carbinoxamine—Tachycardia—Alitretinoin—peripheral nervous system neoplasm	0.000625	0.00282	CcSEcCtD
Carbinoxamine—Hyperhidrosis—Alitretinoin—peripheral nervous system neoplasm	0.000619	0.00279	CcSEcCtD
Carbinoxamine—Asthenia—Topotecan—peripheral nervous system neoplasm	0.000612	0.00275	CcSEcCtD
Carbinoxamine—Anorexia—Alitretinoin—peripheral nervous system neoplasm	0.000611	0.00275	CcSEcCtD
Carbinoxamine—Asthenia—Tretinoin—peripheral nervous system neoplasm	0.000607	0.00273	CcSEcCtD
Carbinoxamine—Asthenia—Isotretinoin—peripheral nervous system neoplasm	0.000607	0.00273	CcSEcCtD
Carbinoxamine—Thrombocytopenia—Vincristine—peripheral nervous system neoplasm	0.000605	0.00272	CcSEcCtD
Carbinoxamine—Photosensitivity—Doxorubicin—peripheral nervous system neoplasm	0.000601	0.00271	CcSEcCtD
Carbinoxamine—Decreased appetite—Dactinomycin—peripheral nervous system neoplasm	0.000601	0.0027	CcSEcCtD
Carbinoxamine—Asthenia—Melphalan—peripheral nervous system neoplasm	0.000599	0.0027	CcSEcCtD
Carbinoxamine—Hypotension—Alitretinoin—peripheral nervous system neoplasm	0.000599	0.0027	CcSEcCtD
Carbinoxamine—Hyperhidrosis—Vincristine—peripheral nervous system neoplasm	0.000597	0.00269	CcSEcCtD
Carbinoxamine—Fatigue—Dactinomycin—peripheral nervous system neoplasm	0.000596	0.00268	CcSEcCtD
Carbinoxamine—Anorexia—Vincristine—peripheral nervous system neoplasm	0.000589	0.00265	CcSEcCtD
Carbinoxamine—Diarrhoea—Topotecan—peripheral nervous system neoplasm	0.000583	0.00263	CcSEcCtD
Carbinoxamine—Convulsion—Cisplatin—peripheral nervous system neoplasm	0.00058	0.00261	CcSEcCtD
Carbinoxamine—Insomnia—Alitretinoin—peripheral nervous system neoplasm	0.00058	0.00261	CcSEcCtD
Carbinoxamine—Diarrhoea—Tretinoin—peripheral nervous system neoplasm	0.000579	0.0026	CcSEcCtD
Carbinoxamine—Diarrhoea—Isotretinoin—peripheral nervous system neoplasm	0.000579	0.0026	CcSEcCtD
Carbinoxamine—Hypotension—Vincristine—peripheral nervous system neoplasm	0.000577	0.0026	CcSEcCtD
Carbinoxamine—Paraesthesia—Alitretinoin—peripheral nervous system neoplasm	0.000575	0.00259	CcSEcCtD
Carbinoxamine—Diarrhoea—Melphalan—peripheral nervous system neoplasm	0.000571	0.00257	CcSEcCtD
Carbinoxamine—Diplopia—Epirubicin—peripheral nervous system neoplasm	0.00057	0.00257	CcSEcCtD
Carbinoxamine—Somnolence—Alitretinoin—peripheral nervous system neoplasm	0.00057	0.00256	CcSEcCtD
Carbinoxamine—Feeling abnormal—Dactinomycin—peripheral nervous system neoplasm	0.000569	0.00256	CcSEcCtD
Carbinoxamine—Dyspepsia—Alitretinoin—peripheral nervous system neoplasm	0.000564	0.00254	CcSEcCtD
Carbinoxamine—Dizziness—Topotecan—peripheral nervous system neoplasm	0.000564	0.00254	CcSEcCtD
Carbinoxamine—Dizziness—Tretinoin—peripheral nervous system neoplasm	0.000559	0.00252	CcSEcCtD
Carbinoxamine—Dizziness—Isotretinoin—peripheral nervous system neoplasm	0.000559	0.00252	CcSEcCtD
Carbinoxamine—Insomnia—Vincristine—peripheral nervous system neoplasm	0.000558	0.00251	CcSEcCtD
Carbinoxamine—Decreased appetite—Alitretinoin—peripheral nervous system neoplasm	0.000557	0.00251	CcSEcCtD
Carbinoxamine—Paraesthesia—Vincristine—peripheral nervous system neoplasm	0.000554	0.0025	CcSEcCtD
Carbinoxamine—Fatigue—Alitretinoin—peripheral nervous system neoplasm	0.000552	0.00249	CcSEcCtD
Carbinoxamine—Vertigo—Etoposide—peripheral nervous system neoplasm	0.000551	0.00248	CcSEcCtD
Carbinoxamine—Constipation—Alitretinoin—peripheral nervous system neoplasm	0.000548	0.00247	CcSEcCtD
Carbinoxamine—Vomiting—Topotecan—peripheral nervous system neoplasm	0.000542	0.00244	CcSEcCtD
Carbinoxamine—Vomiting—Tretinoin—peripheral nervous system neoplasm	0.000538	0.00242	CcSEcCtD
Carbinoxamine—Vomiting—Isotretinoin—peripheral nervous system neoplasm	0.000538	0.00242	CcSEcCtD
Carbinoxamine—Decreased appetite—Vincristine—peripheral nervous system neoplasm	0.000537	0.00242	CcSEcCtD
Carbinoxamine—Thrombocytopenia—Cisplatin—peripheral nervous system neoplasm	0.000535	0.00241	CcSEcCtD
Carbinoxamine—Headache—Topotecan—peripheral nervous system neoplasm	0.000534	0.0024	CcSEcCtD
Carbinoxamine—Tachycardia—Cisplatin—peripheral nervous system neoplasm	0.000533	0.0024	CcSEcCtD
Carbinoxamine—Fatigue—Vincristine—peripheral nervous system neoplasm	0.000532	0.0024	CcSEcCtD
Carbinoxamine—Convulsion—Etoposide—peripheral nervous system neoplasm	0.000531	0.00239	CcSEcCtD
Carbinoxamine—Vomiting—Melphalan—peripheral nervous system neoplasm	0.000531	0.00239	CcSEcCtD
Carbinoxamine—Headache—Tretinoin—peripheral nervous system neoplasm	0.00053	0.00238	CcSEcCtD
Carbinoxamine—Headache—Isotretinoin—peripheral nervous system neoplasm	0.00053	0.00238	CcSEcCtD
Carbinoxamine—Feeling abnormal—Alitretinoin—peripheral nervous system neoplasm	0.000528	0.00238	CcSEcCtD
Carbinoxamine—Constipation—Vincristine—peripheral nervous system neoplasm	0.000528	0.00238	CcSEcCtD
Carbinoxamine—Diplopia—Doxorubicin—peripheral nervous system neoplasm	0.000528	0.00238	CcSEcCtD
Carbinoxamine—Hyperhidrosis—Cisplatin—peripheral nervous system neoplasm	0.000528	0.00238	CcSEcCtD
Carbinoxamine—Anorexia—Cisplatin—peripheral nervous system neoplasm	0.00052	0.00234	CcSEcCtD
Carbinoxamine—Hypotension—Cisplatin—peripheral nervous system neoplasm	0.00051	0.0023	CcSEcCtD
Carbinoxamine—Urticaria—Alitretinoin—peripheral nervous system neoplasm	0.000509	0.00229	CcSEcCtD
Carbinoxamine—Nausea—Topotecan—peripheral nervous system neoplasm	0.000506	0.00228	CcSEcCtD
Carbinoxamine—Confusional state—Etoposide—peripheral nervous system neoplasm	0.000504	0.00227	CcSEcCtD
Carbinoxamine—Nausea—Isotretinoin—peripheral nervous system neoplasm	0.000502	0.00226	CcSEcCtD
Carbinoxamine—Nausea—Tretinoin—peripheral nervous system neoplasm	0.000502	0.00226	CcSEcCtD
Carbinoxamine—Asthenia—Dactinomycin—peripheral nervous system neoplasm	0.000496	0.00223	CcSEcCtD
Carbinoxamine—Nausea—Melphalan—peripheral nervous system neoplasm	0.000496	0.00223	CcSEcCtD
Carbinoxamine—Paraesthesia—Cisplatin—peripheral nervous system neoplasm	0.00049	0.00221	CcSEcCtD
Carbinoxamine—Thrombocytopenia—Etoposide—peripheral nervous system neoplasm	0.00049	0.0022	CcSEcCtD
Carbinoxamine—Tachycardia—Etoposide—peripheral nervous system neoplasm	0.000488	0.0022	CcSEcCtD
Carbinoxamine—Hyperhidrosis—Etoposide—peripheral nervous system neoplasm	0.000484	0.00218	CcSEcCtD
Carbinoxamine—Anorexia—Etoposide—peripheral nervous system neoplasm	0.000477	0.00215	CcSEcCtD
Carbinoxamine—Decreased appetite—Cisplatin—peripheral nervous system neoplasm	0.000475	0.00214	CcSEcCtD
Carbinoxamine—Diarrhoea—Dactinomycin—peripheral nervous system neoplasm	0.000473	0.00213	CcSEcCtD
Carbinoxamine—Hypotension—Etoposide—peripheral nervous system neoplasm	0.000467	0.0021	CcSEcCtD
Carbinoxamine—Asthenia—Alitretinoin—peripheral nervous system neoplasm	0.00046	0.00207	CcSEcCtD
Carbinoxamine—Pollakiuria—Epirubicin—peripheral nervous system neoplasm	0.000455	0.00205	CcSEcCtD
Carbinoxamine—Photosensitivity reaction—Epirubicin—peripheral nervous system neoplasm	0.00045	0.00203	CcSEcCtD
Carbinoxamine—Feeling abnormal—Cisplatin—peripheral nervous system neoplasm	0.00045	0.00203	CcSEcCtD
Carbinoxamine—Paraesthesia—Etoposide—peripheral nervous system neoplasm	0.000449	0.00202	CcSEcCtD
Carbinoxamine—Somnolence—Etoposide—peripheral nervous system neoplasm	0.000445	0.002	CcSEcCtD
Carbinoxamine—Asthenia—Vincristine—peripheral nervous system neoplasm	0.000443	0.00199	CcSEcCtD
Carbinoxamine—Drowsiness—Epirubicin—peripheral nervous system neoplasm	0.00044	0.00198	CcSEcCtD
Carbinoxamine—Vomiting—Dactinomycin—peripheral nervous system neoplasm	0.000439	0.00198	CcSEcCtD
Carbinoxamine—Diarrhoea—Alitretinoin—peripheral nervous system neoplasm	0.000438	0.00197	CcSEcCtD
Carbinoxamine—Decreased appetite—Etoposide—peripheral nervous system neoplasm	0.000435	0.00196	CcSEcCtD
Carbinoxamine—Fatigue—Etoposide—peripheral nervous system neoplasm	0.000431	0.00194	CcSEcCtD
Carbinoxamine—Neuropathy peripheral—Epirubicin—peripheral nervous system neoplasm	0.000431	0.00194	CcSEcCtD
Carbinoxamine—Constipation—Etoposide—peripheral nervous system neoplasm	0.000428	0.00193	CcSEcCtD
Carbinoxamine—Dizziness—Alitretinoin—peripheral nervous system neoplasm	0.000424	0.00191	CcSEcCtD
Carbinoxamine—Diarrhoea—Vincristine—peripheral nervous system neoplasm	0.000422	0.0019	CcSEcCtD
Carbinoxamine—Pollakiuria—Doxorubicin—peripheral nervous system neoplasm	0.000421	0.0019	CcSEcCtD
Carbinoxamine—Photosensitivity reaction—Doxorubicin—peripheral nervous system neoplasm	0.000416	0.00187	CcSEcCtD
Carbinoxamine—Feeling abnormal—Etoposide—peripheral nervous system neoplasm	0.000412	0.00186	CcSEcCtD
Carbinoxamine—Nausea—Dactinomycin—peripheral nervous system neoplasm	0.00041	0.00185	CcSEcCtD
Carbinoxamine—Agranulocytosis—Epirubicin—peripheral nervous system neoplasm	0.00041	0.00185	CcSEcCtD
Carbinoxamine—Dizziness—Vincristine—peripheral nervous system neoplasm	0.000408	0.00184	CcSEcCtD
Carbinoxamine—Vomiting—Alitretinoin—peripheral nervous system neoplasm	0.000407	0.00183	CcSEcCtD
Carbinoxamine—Drowsiness—Doxorubicin—peripheral nervous system neoplasm	0.000407	0.00183	CcSEcCtD
Carbinoxamine—Headache—Alitretinoin—peripheral nervous system neoplasm	0.000401	0.00181	CcSEcCtD
Carbinoxamine—Neuropathy peripheral—Doxorubicin—peripheral nervous system neoplasm	0.000399	0.00179	CcSEcCtD
Carbinoxamine—Urticaria—Etoposide—peripheral nervous system neoplasm	0.000397	0.00179	CcSEcCtD
Carbinoxamine—Vomiting—Vincristine—peripheral nervous system neoplasm	0.000393	0.00177	CcSEcCtD
Carbinoxamine—Asthenia—Cisplatin—peripheral nervous system neoplasm	0.000392	0.00176	CcSEcCtD
Carbinoxamine—Headache—Vincristine—peripheral nervous system neoplasm	0.000387	0.00174	CcSEcCtD
Carbinoxamine—Nausea—Alitretinoin—peripheral nervous system neoplasm	0.000381	0.00171	CcSEcCtD
Carbinoxamine—Agranulocytosis—Doxorubicin—peripheral nervous system neoplasm	0.00038	0.00171	CcSEcCtD
Carbinoxamine—Diarrhoea—Cisplatin—peripheral nervous system neoplasm	0.000374	0.00168	CcSEcCtD
Carbinoxamine—Tinnitus—Epirubicin—peripheral nervous system neoplasm	0.000368	0.00166	CcSEcCtD
Carbinoxamine—Nausea—Vincristine—peripheral nervous system neoplasm	0.000367	0.00165	CcSEcCtD
Carbinoxamine—Asthenia—Etoposide—peripheral nervous system neoplasm	0.000359	0.00162	CcSEcCtD
Carbinoxamine—Chills—Epirubicin—peripheral nervous system neoplasm	0.000354	0.00159	CcSEcCtD
Carbinoxamine—Vomiting—Cisplatin—peripheral nervous system neoplasm	0.000347	0.00156	CcSEcCtD
Carbinoxamine—Diarrhoea—Etoposide—peripheral nervous system neoplasm	0.000342	0.00154	CcSEcCtD
Carbinoxamine—Tinnitus—Doxorubicin—peripheral nervous system neoplasm	0.00034	0.00153	CcSEcCtD
Carbinoxamine—Tension—Epirubicin—peripheral nervous system neoplasm	0.000337	0.00152	CcSEcCtD
Carbinoxamine—Nervousness—Epirubicin—peripheral nervous system neoplasm	0.000334	0.0015	CcSEcCtD
Carbinoxamine—Dizziness—Etoposide—peripheral nervous system neoplasm	0.000331	0.00149	CcSEcCtD
Carbinoxamine—Chills—Doxorubicin—peripheral nervous system neoplasm	0.000328	0.00147	CcSEcCtD
Carbinoxamine—Nausea—Cisplatin—peripheral nervous system neoplasm	0.000324	0.00146	CcSEcCtD
Carbinoxamine—Vision blurred—Epirubicin—peripheral nervous system neoplasm	0.000324	0.00146	CcSEcCtD
Carbinoxamine—Vomiting—Etoposide—peripheral nervous system neoplasm	0.000318	0.00143	CcSEcCtD
Carbinoxamine—Agitation—Epirubicin—peripheral nervous system neoplasm	0.000316	0.00142	CcSEcCtD
Carbinoxamine—Headache—Etoposide—peripheral nervous system neoplasm	0.000313	0.00141	CcSEcCtD
Carbinoxamine—Tension—Doxorubicin—peripheral nervous system neoplasm	0.000312	0.0014	CcSEcCtD
Carbinoxamine—Nervousness—Doxorubicin—peripheral nervous system neoplasm	0.000309	0.00139	CcSEcCtD
Carbinoxamine—Vertigo—Epirubicin—peripheral nervous system neoplasm	0.000309	0.00139	CcSEcCtD
Carbinoxamine—Palpitations—Epirubicin—peripheral nervous system neoplasm	0.000304	0.00137	CcSEcCtD
Carbinoxamine—Vision blurred—Doxorubicin—peripheral nervous system neoplasm	0.0003	0.00135	CcSEcCtD
Carbinoxamine—Convulsion—Epirubicin—peripheral nervous system neoplasm	0.000298	0.00134	CcSEcCtD
Carbinoxamine—Nausea—Etoposide—peripheral nervous system neoplasm	0.000297	0.00134	CcSEcCtD
Carbinoxamine—Agitation—Doxorubicin—peripheral nervous system neoplasm	0.000292	0.00131	CcSEcCtD
Carbinoxamine—Vertigo—Doxorubicin—peripheral nervous system neoplasm	0.000286	0.00129	CcSEcCtD
Carbinoxamine—Confusional state—Epirubicin—peripheral nervous system neoplasm	0.000283	0.00127	CcSEcCtD
Carbinoxamine—Palpitations—Doxorubicin—peripheral nervous system neoplasm	0.000281	0.00126	CcSEcCtD
Carbinoxamine—Convulsion—Doxorubicin—peripheral nervous system neoplasm	0.000275	0.00124	CcSEcCtD
Carbinoxamine—Thrombocytopenia—Epirubicin—peripheral nervous system neoplasm	0.000275	0.00124	CcSEcCtD
Carbinoxamine—Tachycardia—Epirubicin—peripheral nervous system neoplasm	0.000274	0.00123	CcSEcCtD
Carbinoxamine—Hyperhidrosis—Epirubicin—peripheral nervous system neoplasm	0.000271	0.00122	CcSEcCtD
Carbinoxamine—Anorexia—Epirubicin—peripheral nervous system neoplasm	0.000267	0.0012	CcSEcCtD
Carbinoxamine—Hypotension—Epirubicin—peripheral nervous system neoplasm	0.000262	0.00118	CcSEcCtD
Carbinoxamine—Confusional state—Doxorubicin—peripheral nervous system neoplasm	0.000262	0.00118	CcSEcCtD
Carbinoxamine—Thrombocytopenia—Doxorubicin—peripheral nervous system neoplasm	0.000254	0.00114	CcSEcCtD
Carbinoxamine—Insomnia—Epirubicin—peripheral nervous system neoplasm	0.000254	0.00114	CcSEcCtD
Carbinoxamine—Tachycardia—Doxorubicin—peripheral nervous system neoplasm	0.000253	0.00114	CcSEcCtD
Carbinoxamine—Paraesthesia—Epirubicin—peripheral nervous system neoplasm	0.000252	0.00113	CcSEcCtD
Carbinoxamine—Hyperhidrosis—Doxorubicin—peripheral nervous system neoplasm	0.000251	0.00113	CcSEcCtD
Carbinoxamine—Somnolence—Epirubicin—peripheral nervous system neoplasm	0.000249	0.00112	CcSEcCtD
Carbinoxamine—Anorexia—Doxorubicin—peripheral nervous system neoplasm	0.000247	0.00111	CcSEcCtD
Carbinoxamine—Dyspepsia—Epirubicin—peripheral nervous system neoplasm	0.000247	0.00111	CcSEcCtD
Carbinoxamine—Decreased appetite—Epirubicin—peripheral nervous system neoplasm	0.000244	0.0011	CcSEcCtD
Carbinoxamine—Hypotension—Doxorubicin—peripheral nervous system neoplasm	0.000242	0.00109	CcSEcCtD
Carbinoxamine—Fatigue—Epirubicin—peripheral nervous system neoplasm	0.000242	0.00109	CcSEcCtD
Carbinoxamine—Constipation—Epirubicin—peripheral nervous system neoplasm	0.00024	0.00108	CcSEcCtD
Carbinoxamine—Insomnia—Doxorubicin—peripheral nervous system neoplasm	0.000235	0.00106	CcSEcCtD
Carbinoxamine—Paraesthesia—Doxorubicin—peripheral nervous system neoplasm	0.000233	0.00105	CcSEcCtD
Carbinoxamine—Feeling abnormal—Epirubicin—peripheral nervous system neoplasm	0.000231	0.00104	CcSEcCtD
Carbinoxamine—Somnolence—Doxorubicin—peripheral nervous system neoplasm	0.000231	0.00104	CcSEcCtD
Carbinoxamine—Dyspepsia—Doxorubicin—peripheral nervous system neoplasm	0.000228	0.00103	CcSEcCtD
Carbinoxamine—Decreased appetite—Doxorubicin—peripheral nervous system neoplasm	0.000226	0.00102	CcSEcCtD
Carbinoxamine—Fatigue—Doxorubicin—peripheral nervous system neoplasm	0.000224	0.00101	CcSEcCtD
Carbinoxamine—Urticaria—Epirubicin—peripheral nervous system neoplasm	0.000223	0.001	CcSEcCtD
Carbinoxamine—Constipation—Doxorubicin—peripheral nervous system neoplasm	0.000222	0.000999	CcSEcCtD
Carbinoxamine—Feeling abnormal—Doxorubicin—peripheral nervous system neoplasm	0.000214	0.000962	CcSEcCtD
Carbinoxamine—Urticaria—Doxorubicin—peripheral nervous system neoplasm	0.000206	0.000928	CcSEcCtD
Carbinoxamine—Asthenia—Epirubicin—peripheral nervous system neoplasm	0.000201	0.000906	CcSEcCtD
Carbinoxamine—Diarrhoea—Epirubicin—peripheral nervous system neoplasm	0.000192	0.000864	CcSEcCtD
Carbinoxamine—Asthenia—Doxorubicin—peripheral nervous system neoplasm	0.000186	0.000838	CcSEcCtD
Carbinoxamine—Dizziness—Epirubicin—peripheral nervous system neoplasm	0.000185	0.000835	CcSEcCtD
Carbinoxamine—Vomiting—Epirubicin—peripheral nervous system neoplasm	0.000178	0.000802	CcSEcCtD
Carbinoxamine—Diarrhoea—Doxorubicin—peripheral nervous system neoplasm	0.000177	0.000799	CcSEcCtD
Carbinoxamine—Headache—Epirubicin—peripheral nervous system neoplasm	0.000176	0.000791	CcSEcCtD
Carbinoxamine—Dizziness—Doxorubicin—peripheral nervous system neoplasm	0.000172	0.000772	CcSEcCtD
Carbinoxamine—Nausea—Epirubicin—peripheral nervous system neoplasm	0.000167	0.00075	CcSEcCtD
Carbinoxamine—Vomiting—Doxorubicin—peripheral nervous system neoplasm	0.000165	0.000743	CcSEcCtD
Carbinoxamine—Headache—Doxorubicin—peripheral nervous system neoplasm	0.000163	0.000732	CcSEcCtD
Carbinoxamine—Nausea—Doxorubicin—peripheral nervous system neoplasm	0.000154	0.000694	CcSEcCtD
